Skip to content

Gross margin at other companies

Abbott logo
AbbottABT
56.3%+0.4pp
DexCom logo
DexComDXCM
61.5%+2.1pp
Medtronic logo
MedtronicMDT
65%-0.3pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
54.9%+2.7pp
Embecta Corp. logo
Embecta Corp.EMBC
61.9%-1.6pp
Owlet logo
OwletOWLT
50.9%-1.4pp

Other financials

Income statement

See full
Revenue$11.7M+87.2%
Gross profit$6.9M+361%
Operating income-$31.8M-136%
Net income-$32.3M-127%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$29.6M-24.7%
Total debt$43.1M+5.0%
Total equity$34.3M-2.4%
Total assets$102.9M+17.9%

Cash flow

See full
Operating cash flow-$32.0M-99.2%
CapEx$111.0K-74.4%
Free cash flow-$32.1M-94.6%

Valuation

See full
Market cap$296.51M-21.4%
Enterprise value$310.04M-19.9%
P/S7.3×-7.5×

Profitability

See full
Operating margin-213%-46.7pp
Net margin-214.1%-51.2pp
FCF margin-186.4%-37.0pp

Returns & leverage

See full
Return on equity-250.7%-19.0pp
Debt / equity1.3×+0.1×
Current ratio3.5×-3.4×

Where this comes from

Calculated from Senseonics Holdings, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: Senseonics Holdings, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Senseonics Holdings, Inc. 's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Senseonics Holdings, Inc. 's gross margin?
Senseonics Holdings, Inc. (SENS) reported gross margin of 52.1% in Q1 2026.
How has Senseonics Holdings, Inc. 's gross margin changed year-over-year?
Senseonics Holdings, Inc. 's gross margin increased by 624.1% year-over-year, from 7.2% to 52.1%.
What is the long-term trend for Senseonics Holdings, Inc. 's gross margin?
Over 5 years (2020 to 2025), Senseonics Holdings, Inc. 's gross margin has grown at a -33.8% compound annual growth rate (CAGR), from -350.9% to 44.7%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.